What is the long-term trend for Caterpillar's defined benefit plan, expected gross prescription drug subsidy receipts?

Over 2 years (2023 to 2025), Caterpillar's defined benefit plan, expected gross prescription drug subsidy receipts has grown at a -5.5% compound annual growth rate (CAGR), from $47.00M to $42.00M.

Other

Defined Benefit Plan, Expected Gross Prescription Drug Subsidy Receipts

Caterpillar Defined Benefit Plan, Expected Gross Prescription Drug Subsidy Receipts decreased by 8.7% to $42.00M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Defined Benefit Plan, Expected Gross Prescription Drug Subsidy Receipts shows a downward trend with a -5.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryEfficiency

SignalHigher is better

VolatilityStable

First reportedQ4 2023

Last reportedQ4 2025Feb 13, 2026

How to read this metric

Higher gross receipts indicate a greater degree of government cost-sharing, which improves the company's net benefit expense profile.

Detailed definition

This represents the total expected gross cash inflows from government subsidies related to prescription drug benefits pr...

Peer comparison

Standard disclosure for companies with significant legacy retiree healthcare liabilities.

Metric ID: other_defined_benefit_plan_expected_gross_prescription_d_94f6c2

Historical Data

3 periods

	Q4 '23	Q4 '24	Q4 '25
Value	$47.00M	$46.00M	$42.00M
QoQ Change	—	-2.1%	-8.7%
YoY Change	—	-2.1%	-8.7%

Range$42.00M – $47.00M

Avg YoY Growth-5.4%

Median YoY Growth-5.4%

Current Streak2+ quarters decline

Defined Benefit Plan, Expected Gross Prescription Drug Subsidy Receipts at Other Companies

AmerenAEE View metric

Prudential FinancialPRU View metric

Frequently Asked Questions

What is Caterpillar's defined benefit plan, expected gross prescription drug subsidy receipts?: Caterpillar (CAT) reported defined benefit plan, expected gross prescription drug subsidy receipts of $42.00M in Q4 2025.
What is the long-term trend for Caterpillar's defined benefit plan, expected gross prescription drug subsidy receipts?: Over 2 years (2023 to 2025), Caterpillar's defined benefit plan, expected gross prescription drug subsidy receipts has grown at a -5.5% compound annual growth rate (CAGR), from $47.00M to $42.00M.
What does defined benefit plan, expected gross prescription drug subsidy receipts mean?: The total expected gross government payments for retiree prescription drug costs.